SYON CAPITAL LLC

Position in JNJ — Johnson & Johnson

CIK 1999353 SAN FRANCISCO, CA

Position in JNJ

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$7,171,380

+$1,126,164 QoQ

Shares Held

29,338

+0.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.56%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SYON CAPITAL LLC holds $41,641,759 across 15 Drug Manufacturers - General names. JNJ ranks #2 (17.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	12,819	$11,790,531
2	JNJ	Johnson & Johnson This page	29,338	$7,171,380
3	ABBV	AbbVie Inc.	25,838	$5,619,506
4	MRK	Merck & Co., Inc.	25,670	$3,087,844
5	AMGN	Amgen Inc	8,271	$2,910,151
6	GILD	Gilead Sciences, Inc.	20,745	$2,891,230
7	AZN	Astrazeneca PLC	11,958	$2,358,356
8	GSK	GSK plc	29,471	$1,626,504

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,171,380	29,338	+0.4%	Shares	Sole	2026-05-13
2025-12-31	$6,045,216	29,211	+7.0%	Shares	Sole	2026-02-11
2025-09-30	$5,061,409	27,297	+3.4%	Shares	Sole	2025-11-07
2025-06-30	$4,033,058	26,403	-10.3%	Shares	Sole	2025-08-14
2025-03-31	$4,882,495	29,441	+13.2%	Shares	Sole	2025-05-15
2024-12-31	$3,759,686	25,997	-0.9%	Shares	Sole	2025-02-14
2024-09-30	$4,249,699	26,223	-16.6%	Shares	Sole	2024-11-13
2024-06-30	$4,597,608	31,456	+2.7%	Shares	Sole	2024-08-13
2024-03-31	$4,847,257	30,642	+13.3%	Shares	Sole	2024-05-14
2023-12-31	$4,238,406	27,041	+44.2%	Shares	Sole	2024-02-26
2023-09-30	$2,920,156	18,749	—	Shares	Sole	2023-11-03
No filing history on record for this holder in this stock.